Generic Ozempic Hits Canadian Pharmacy Shelves

Two generic versions of semaglutide, the active ingredient in Ozempic, are arriving in Canadian pharmacies this week, offering patients a lower-cost alternative for diabetes and weight loss treatment.

Health Canada approved generic versions from Dr. Reddy's Laboratories (India-based) and Apotex (Canada-based) roughly three weeks ago. Apotex began shipping its product on Tuesday, while Dr. Reddy's says its version has already arrived at select Canadian locations.

The availability matters because brand-name Ozempic carries a significant price tag. Generic versions typically cost a fraction of the original, making the drug more accessible to patients who either can't afford the brand name or face insurance coverage gaps.

The medications are approved for treating type 2 diabetes and, in some cases, for weight management. The market for semaglutide has exploded in recent years as demand for GLP-1 receptor agonists has surged globally. Canada, like many countries, has seen shortages and supply challenges as demand outpaced production.

Pharmacy shelves moving from brand-exclusive to multi-generic supply typically stabilizes pricing and availability. Patients should expect their pharmacist to offer options when filling prescriptions, and insurance coverage may shift as generics become standard. For those who've waited for affordable access, this week's arrival marks a significant change in treatment accessibility.